Searchable abstracts of presentations at key conferences in endocrinology

ea0029p39 | Adrenal cortex | ICEECE2012

Reduction of the 10-year probability of fracture predicted by FRAX® and bone mass recovery in patients with Cushing’s Syndrome after 24 months from cure of hypercortisolism

Trementino L. , Ceccoli L. , Marcelli G. , Mancini T. , Boscaro M. , Arnaldi G.

Introduction: Cushing’s Syndrome (CS) has been associated with bone mass abnormalities and with an increased risk of osteoporotic fractures.Objective: Evaluate the effect of treatment on the 10-year probability of fracture predicted by FRAX® and on the overall bone profile, in patients with CS.Patients and Methods: We evaluated 36 patients (6 M, 30 F, 12 post-menopausal, mean-age 43.6±13.5), 22 with Cushin...

ea0026p244 | Pituitary | ECE2011

Hyperprolactinemia is a risk factor for radiological vertebral fractures in post-menopausal women

Mazziotti G , Mancini T , Mormando M , De Menis E , Bianchi A , Doga M , De Marinis L , Giustina A

Hyperprolactinemia may cause bone loss in pre-menopausal women and men. Data on fractures are scanty and it is still unclear which is the skeletal impact of hyperprolactinemia in post-menopausal women. The aim of this study was to evaluate the prevalence of vertebral fractures in post-menopausal women with hyperprolactinemia.Forty post-menopausal women (median age 57 years, range: 47–81) with prolactin (PRL)-secreting adenoma and 119 control post-me...